Literature DB >> 10530586

Effect of the Factor V Leiden mutation on the severity of meningococcal disease.

S Kondaveeti1, M L Hibberd, R Booy, S Nadel, M Levin.   

Abstract

BACKGROUND: One of the most serious complications of meningococcal disease is the syndrome of purpura fulminans, which is characterized by intravascular thrombosis and hemorrhagic infarction of skin, limbs and digits. The reasons why some patients with meningococcal disease develop purpura fulminans while others have minimal thrombotic and skin involvement despite having profound septic shock are not yet understood. The Factor V Leiden mutation (FV(L)) is associated with thrombotic events, and we hypothesized that children carrying FV(L) who develop meningococcal disease may be at increased risk of purpura fulminans.
METHODS: We determined the FV(L) genotype by PCR and restriction enzyme digestion (Mnl1) in 259 children with meningococcal disease and 80 healthy controls. In addition 79 parents of children with fatal meningococcal disease were studied.
RESULTS: There was no significant increase in the frequency of FV(L) in patients with meningococcal disease (10%) as compared with healthy controls (9%) or with the parents of children who died of meningococcal disease (12%). Although the mortality was not increased in patients heterozygous for FV(L), they had increased complications of purpura fulminans, as assessed by requirement for skin grafting, referral to plastic surgeon and/or amputation. Among survivors 5 of 24 (21%) of those heterozygous for FV(L) had complications, compared with 14 of 233 (7%) who were wild type [P < 0.03; relative risk, 3.1 (95% confidence intervals, 1.2 to 7.9)].
CONCLUSIONS: FV(L) exacerbates purpura fulminans in meningococcal disease but does not have a significant effect on mortality.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530586     DOI: 10.1097/00006454-199910000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Genetic susceptibility in sepsis: implications for the pediatric population.

Authors:  Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

2.  Escherichia coli Bacteremia-induced Purpura Fulminans: A Case Report.

Authors:  Mohamed Ahmed; Michael Samotowka; Saba Habis; Ahmed Mahmoud; Rasha Saeed
Journal:  Cureus       Date:  2018-11-26

3.  Understanding purpura fulminans in adult patients.

Authors:  Damien Contou; Tomas Urbina; Nicolas de Prost
Journal:  Intensive Care Med       Date:  2021-11-30       Impact factor: 17.440

4.  Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study.

Authors:  Thomas Benfield; Karen Ejrnaes; Klaus Juul; Christian Østergaard; Jannik Helweg-Larsen; Nina Weis; Lea Munthe-Fog; Gitte Kronborg; Marianne Ring Andersen; Anne Tybjaerg-Hansen; Børge G Nordestgaard; Peter Garred
Journal:  Crit Care       Date:  2010-03-05       Impact factor: 9.097

5.  Neisseria meningitidis C:2b:P1.2,5 with intermediate resistance to penicillin, Portugal.

Authors:  Manuela Caniça; Ricardo Dias; Eugénia Ferreira
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

6.  A Rare Mutation in SPLUNC1 Affects Bacterial Adherence and Invasion in Meningococcal Disease.

Authors:  Bayarchimeg Mashbat; Evangelos Bellos; Stephanie Hodeib; Fadil Bidmos; Ryan S Thwaites; Yaxuan Lu; Victoria J Wright; Jethro A Herberg; Daniela S Klobassa; Werner Zenz; Trevor T Hansel; Simon Nadel; Paul R Langford; Luregn J Schlapbach; Ming-Shi Li; Matthew R Redinbo; Y Peter Di; Michael Levin; Vanessa Sancho-Shimizu
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 20.999

Review 7.  Human genetics of meningococcal infections.

Authors:  Stephanie Hodeib; Jethro A Herberg; Michael Levin; Vanessa Sancho-Shimizu
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.